R&D | November 21, 2025
Lilly expands biotech footprint with new Gateway Labs in Philadelphia
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
This partnership has led to a 10% boost in delivery speed
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
Revenue for the quarter rose 5.8% to Rs. 1,487 crore as compared to Rs. 1,406 crore in the corresponding quarter of the previous fiscal
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
New Phase III data on gefurulimab highlight potential as a self-administered treatment option; real-world evidence reinforces clinical benefits of Ultomiris and Soliris
AI-powered cardiometabolic wellness platform for India’s workforce
This approval marks a significant milestone in women’s health, introducing Bayer’s first hormone-free treatment for menopause-related symptoms
Subscribe To Our Newsletter & Stay Updated
